The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Original Article
Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and Gender Minority Individuals in North Carolina
Abstract
Objectives: Sexual and gender minority (SGM) communities at increased risk of human immunodeficiency virus (HIV) may be underprescribed preexposure prophylaxis (PrEP), but PrEP research on SGM communities other than transgender women and cisgender men who have sex with men is limited. We sought to better understand SGM individuals’ vulnerability to HIV acquisition and awareness and perceptions of PrEP in North Carolina, with a focus on SGM groups less often included in research.Methods: We administered a 37-item online survey to adult SGM participants, examining differences in perceived and behavioral HIV risk based on self-reported behaviors. We also compared PrEP awareness, prescriptions, and stigma between SGM identities and used logistic regression to examine associations between HIV risk and PrEP use.
Results: In total, 372 participants completed the survey. Although 30.9% reported behaviors that increase the likelihood of HIV acquisition, only 9.5% perceived their risk as elevated. Most (78.5%) were aware of PrEP, but only 15.1% had been prescribed PrEP. PrEP stigma was most pervasive among cisgender women. Nonbinary and queer participants were more likely to have experienced mistreatment by a provider (20.3%, P < 0.0001; 19.2%, P < 0.01) and avoid care fearing mistreatment (31.9%, P < 0.001; 27.7%; P < 0.001) compared with the entire sample.
Conclusions: PrEP is prescribed at low rates across many SGM communities, with misperception of HIV risk, PrEP stigma, and mistreatment in health care identified as important barriers. Healthcare providers should take steps to create a safe environment for SGM patients and ask all patients about HIV risk factors and provide information about PrEP regardless of sexual orientation or gender identity.
Posted in: Infectious Disease150 Acquired Immunodeficiency Syndrome (AIDS) And Human Immunodeficiency Virus (HIV) Infection22
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Centers for Disease Control and Prevention. HIV Surveillance Report: diagnoses of HIV infection in the United States and dependent areas, 2021.https://stacks.cdc.gov/view/cdc/14. Published May 1, 2023. Accessed May 5, 2025.
2. Owens DK, Davidson KW, Krist AH, et al. Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force Recommendation Statement. JAMA 2019;321: 2203-2213.
3. McNulty A, Bourne C. Transgender HIV and sexually transmissible infections. Sex Health 2017;14:451-455. .
4. Herbst JH, Jacobs ED, Finlayson TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 2008;12:1-17.
5. Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009-2014. AIDS Behav 2017;21:2774-2783.
6. Morris E, Teplinskaya A, Olansky E, et al. Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020. Morb Mortal Wkly Rep 2024;73(Suppl 1):9-20.
7. Crepaz N, Hess KL, Purcell DW, et al. Estimating national rates of HIV infection among MSM, persons who inject drugs, and heterosexuals in the United States. AIDS 2019;33: 701-708.
8. Reisner SL, Moore CS, Asquith A, et al. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. J Int AIDS Soc 2019;22:e25391.
9. Zarwell M, John SA, Westmoreland D, et al. PrEP Uptake and Discontinuation Among a U.S. National Sample of Transgender Men and Women. AIDS Behav. Apr 2021;25:1063-1071.
10. Wilson EC, Turner CM, Arayasirikul S, et al. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies. J Int AIDS Soc 2020;23(Suppl 3):e25539.
11. Chen YT, Duncan DT, Del Vecchio N, et al. COVID-19-Related Stressors, Sex Behaviors, and HIV Status Neutral Care Among Black Men Who Have Sex With Men and Transgender Women in Chicago, USA. J Acquir Immune Defic Syndr 2021;88:261-271.
12. Garlow EW, Onwubiko UN, Holland DP, et al. Association between having a regular healthcare provider and pre-exposure prophylaxis use among men who have sex with men: a cross-sectional survey. J Behav Med 2022;45:428-437.
13. Malone J, Reisner SL, Cooney EE, et al. Perceived HIVAcquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States. J Acquir Immune Defic Syndr 2021;88:10-18.
14. Bonett S, Dowshen N, Bauermeister J, et al. Characterizing the PrEP Continuum for Black and Latinx Sexual and Gender Minority Youth. AIDS Behav 2022;26:1211-1221.
15. Chandra C, Weiss KM, Kelley CF, et al. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States. Clin Infect Dis 2021;73:e2261-e2269.
16. Cooney EE, Reisner SL, Saleem HT, et al. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study. Ann Epidemiol 2022;70:23-31.
17. Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. J Acquir Immune Defic Syndr 2020;84:437-442.
18. Poteat T, Wirtz A, Malik M, et al. A Gap Between Willingness and Uptake: Findings From Mixed Methods Research on HIV Prevention Among Black and Latina Transgender Women. J Acquir Immune Defic Syndr 2019;82:131-140.
19. Eaton LA, Matthews DD, Driffin DD, et al. A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men. Prev Sci 2017;18:505-516.
20. Fredriksen-Goldsen KI, Simoni JM, Kim HJ, et al. The health equity promotion model: Reconceptualization of lesbian, gay, bisexual, and transgender (LGBT) health disparities. Am J Orthopsychiatry 2014;84:653-663.
21. National Academies of Sciences, Engineering, and Medicine. Understanding the Well-Being of LGBTQI+ Populations. https://nap.nationalacademies.org/catalog/25877/understanding-the-well-being-of-lgbtqi-populations. Published 2020. Accessed May 5, 2025.
22. James SE, Herman JL, Rankin S, et al. Executive Summary of the Report of the 2015 U.S. Transgender Survey. https://transequality.org/sites/default/files/docs/usts/USTS-Executive-Summary-Dec17.pdf. Published December 2016. Accessed May 5, 2025.
23. Wilson EC, Jin H, Liu A, et al. Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013. PLoS One 2015;10:e0128971.
24. D'Avanzo PA, Bass SB, Brajuha J, et al. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis. Behav Med 2019;45:143-152.
25. Dang M, Scheim AI, Teti M, et al. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review. AIDS Patient Care STDS 2022;36:236-248.
26. Rael CT, Martinez M, Giguere R, et al. Knowledge About Oral PrEP Among Transgender Women in New York City. AIDS Behav 2019;23:2779-2783.
27. Sevelius JM, Keatley J, Calma N, et al. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health 2016;11:1060-1075.
28. Wood S, Gross R, Shea JA, et al. Barriers and Facilitators of PrEPAdherence for Young Men and Transgender Women of Color. AIDS Behav 2019;23:2719-2729.
29. Rowniak S, Ong-Flaherty C, Selix N, et al. Attitudes, Beliefs, and Barriers to PrEP Among Trans Men. AIDS Educ Prev 2017;29:302-314.
30. Golub SA. PrEP Stigma: Implicit and Explicit Drivers of Disparity. Curr HIV/AIDS Rep 2018; 15:190-197.
31. Brooks RA, Nieto O, Landrian A, Donohoe TJ. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men. AIDS Care 2019;31:427-435.
32. Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Adv Ther 2020;37:1778-1811.
33. Andrzejewski J, Dunville R, Johns MM, et al. Medical Gender Affirmation and HIV and Sexually Transmitted Disease Prevention in Transgender Youth: Results from the Survey of Today's Adolescent Relationships and Transitions, 2018. LGBT Health 2021;8:181-189.
34. Horvath KJ, Todd K, Arayasirikul S, et al. Underutilization of Pre-Exposure Prophylaxis Services Among Transgender and Nonbinary Youth: Findings from Project Moxie and TechStep. Transgend Health 2019;4:217-221.
35. Reisner SL, Moore CS, Asquith A, et al. The Pre-Exposure Prophylaxis Cascade in At-Risk Transgender Men Who Have Sex with Men in the United States. LGBT Health 2021;8: 116-124. LGBT Health 2021;8: 116-124.
36. Westmoreland DA, Pantalone DW, Patel VV, et al. Demographic, Behavioral, and Geographic Differences Between Men, Transmen, and Transwomen Currently on PrEP, Former PrEP Users, and Those Having Never Used PrEP. AIDS Behav 2020;24:1304-1311.
37. Golub SA, Fikslin RA, Starbuck L, et al. High Rates of PrEP Eligibility but Low Rates of PrEP Access Among a National Sample of Transmasculine Individuals. J Acquir Immune Defic Syndr 2019;82:e1-e7.
38. Harless CM, Nanney AH, Johnson A, et al. The report of the 2019 Southern LGBTQ Health Survey. https://southernequality.org/wp-content/uploads/2019/11/SouthernLGBTQHealthSurvey%E2%80%93FullReport.pdf. Published November 2019. Accessed May 5, 2025.
39. Qualtrics. Homepage. https://www.qualtrics.com/. Accessed May 5, 2025.
40. Siegler AJ, Wiatrek S, Mouhanna F, et al. Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions. AIDS Behav 2020;24:2637-2649.
41. Algarin AB, Hee Shrader C, Hackworth BT, et al. Development and Validation of the Community PrEP-Related Stigma Scale (Community-PSS). AIDS Educ Prev 2021;33: 120-128.
42. Klein H, Washington TA. The Pre-Exposure Prophylaxis (PrEP) Stigma Scale: Preliminary findings from a pilot study. Int Public Health J 2019;11:185-195.
43. US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2021 Update – A Clinical Practice Guideline. https://stacks.cdc.gov/view/cdc/112360. Published 2021. Accessed May 31, 2025.
44. Metzger DS, Metzger D. The Risk Assessment Battery (RAB): validity and reliability. Presented in the Sixth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Alexandria, VA; 1993.
45. Bradley E, Forsberg K, Betts JE, et al. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review. J Womens Health (Larchmt) 2019;28:1272-1285.
46. Centers for Disease Control and Prevention. Stigma and HIV. https://www.cdc.gov/hiv/health-equity/?CDC_AAref_Val=https://www.cdc.gov/hiv/basics/hiv-stigma/index.html. Accessed May 5, 2025.
47. Wood SM, Lee S, Barg FK, et al. Young Transgender Women's Attitudes Toward HIV Preexposure Prophylaxis. J Adolesc Health 2017;60:549-555.
48. Brooks RA, Cabral A, Nieto O, et al. Experiences of Pre-Exposure Prophylaxis Stigma, Social Support, and Information Dissemination Among Black and Latina Transgender Women Who Are Using Pre-Exposure Prophylaxis. Transgend Health 2019;4:188-196.
49. Chandler CJ, Creasy SL, Adams BJ, et al. Characterizing Biomedical HIV Prevention Awareness and Use Among Black Transgender Women in the United States. AIDS Behav 2021;25:2929-2940.
50. Roemerman RM, Wright ER, Simpkins J, et al. Southern survey key findings: Conditions and life experiences of LGBTQ southerners. https://static1.squarespace.com/static/5babfcebe666695a32c2a4c9/t/61b4300bb456ab7d390df53d/1724689637738/General%20+Survey+Report+Key+Findings.pdf. Published 2018. Accessed May 5, 2025.
51. Goldberg AE, Kuvalanka KA, Budge SL, et al. Health Care Experiences of Transgender Binary and Nonbinary University Students. Couns Psychol 2019;(47):59-97.
52. Liszewski W, Peebles JK, Yeung H, et al. Persons of Nonbinary Gender - Awareness, Visibility, and Health Disparities. N Engl J Med 2018;379:2391-2393.
53. Reisner SL, Hughto JMW. Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample. PLoS One 2019;14:e0221583.
54. Nicholas L. Queer ethics and fostering positive mindsets toward non-binary gender, genderqueer, and gender ambiguity. Int J Transgend 2019;20:169-180.
55. Biello KB, Oldenburg CE, Mitty JA, et al. The "Safe Sex" Conundrum: Anticipated Stigma From Sexual Partners as a Barrier to PrEP Use Among Substance Using MSM Engaging in Transactional Sex. AIDS Behav 2017;21:300-306.
56. Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEPAmong Black and White Men and Transgender Women Who Have Sex with Men. AIDS Behav 2017;21: 1236-1246.
57. Gillespie D, Williams A, Wood F, et al. Psychometric Properties of an Adapted Stigma Scale and Experiences of Stigma Associated with HIV Pre-exposure Prophylaxis Use Among Men Who have Sex with Men: A Mixed Methods Study. AIDS Behav 2023;27:2397-2410.
58. Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, et al. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS 2015;29:837-845.
59. Census Reporter. American Community Survey 5-year estimates: North Carolina. 2020. https://censusreporter.org/profiles/04000US37-north-carolina/. Accessed May 5, 2025.
